The World Health Organization announced on the 26th that US $31.3 billion will be needed in the next 12 months to develop and deliver COVID-19 drugs, testing tools and vaccines, including purchasing 2 billion doses of vaccines by the end of 2021, of which 1 billion doses will be used in low-and middle-income countries.
On the same day, WHO updated the investment needs of its international cooperation initiative "Obtaining Tool Accelerator to Fight novel coronavirus pneumonia". WHO said that the initiative will focus on the four pillars of diagnosis, therapy, vaccines and connectivity between health systems and community networks. It is estimated that the investment required in the next 12 months will reach 31.3 billion US dollars, of which 3.4 billion US dollars have been pledged and 13.7 billion US dollars out of the remaining 27.9 billion US dollars are urgently needed.
In addition, WHO plans to deliver 500 million COVID-19 testing tools and 245 million courses of therapeutic drugs to low-and middle-income countries by mid-2021, and to provide 2 billion doses of COVID-19 vaccines to the world by the end of 2021, of which 1 billion doses will be used in low-and middle-income countries.
WHO Director-General Tedros said at a regular press conference on the same day that in order to control the TCOVID-19 epidemic and save lives, effective vaccines, diagnostic tools and therapies need to be provided in an unprecedented number and speed. All people are at risk of contracting the COVID-19, so all people should have the tools to prevent, discover and treat the COVID-19, not just those who can afford it.